420 related articles for article (PubMed ID: 33671099)
1. Methylxanthines and Neurodegenerative Diseases: An Update.
Janitschke D; Lauer AA; Bachmann CM; Grimm HS; Hartmann T; Grimm MOW
Nutrients; 2021 Feb; 13(3):. PubMed ID: 33671099
[TBL] [Abstract][Full Text] [Related]
2. Unique Role of Caffeine Compared to Other Methylxanthines (Theobromine, Theophylline, Pentoxifylline, Propentofylline) in Regulation of AD Relevant Genes in Neuroblastoma SH-SY5Y Wild Type Cells.
Janitschke D; Lauer AA; Bachmann CM; Seyfried M; Grimm HS; Hartmann T; Grimm MOW
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33260941
[TBL] [Abstract][Full Text] [Related]
3. Methylxanthines Induce a Change in the AD/Neurodegeneration-Linked Lipid Profile in Neuroblastoma Cells.
Janitschke D; Lauer AA; Bachmann CM; Winkler J; Griebsch LV; Pilz SM; Theiss EL; Grimm HS; Hartmann T; Grimm MOW
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216410
[TBL] [Abstract][Full Text] [Related]
4. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.
Chen JF; Chern Y
Handb Exp Pharmacol; 2011; (200):267-310. PubMed ID: 20859800
[TBL] [Abstract][Full Text] [Related]
5. Health benefits of methylxanthines in neurodegenerative diseases.
Oñatibia-Astibia A; Franco R; Martínez-Pinilla E
Mol Nutr Food Res; 2017 Jun; 61(6):. PubMed ID: 28074613
[TBL] [Abstract][Full Text] [Related]
6. Effect of Caffeine and Other Methylxanthines on Aβ-Homeostasis in SH-SY5Y Cells.
Janitschke D; Nelke C; Lauer AA; Regner L; Winkler J; Thiel A; Grimm HS; Hartmann T; Grimm MOW
Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31684105
[TBL] [Abstract][Full Text] [Related]
7. Topology of the interactions pattern in pharmaceutically relevant polymorphs of methylxanthines (caffeine, theobromine, and theophiline): combined experimental (¹H-¹⁴N nuclear quadrupole double resonance) and computational (DFT and Hirshfeld-based) study.
Latosińska JN; Latosińska M; Olejniczak GA; Seliger J; Žagar V
J Chem Inf Model; 2014 Sep; 54(9):2570-84. PubMed ID: 25184363
[TBL] [Abstract][Full Text] [Related]
8. Structure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the Drawbacks.
Monteiro JP; Alves MG; Oliveira PF; Silva BM
Molecules; 2016 Jul; 21(8):. PubMed ID: 27472311
[TBL] [Abstract][Full Text] [Related]
9. Impact of Coffee and Cacao Purine Metabolites on Neuroplasticity and Neurodegenerative Disease.
Camandola S; Plick N; Mattson MP
Neurochem Res; 2019 Jan; 44(1):214-227. PubMed ID: 29417473
[TBL] [Abstract][Full Text] [Related]
10. Testicular atrophy and impaired spermatogenesis in rats fed high levels of the methylxanthines caffeine, theobromine, or theophylline.
Friedman L; Weinberger MA; Farber TM; Moreland FM; Peters EL; Gilmore CE; Khan MA
J Environ Pathol Toxicol; 1979; 2(3):687-706. PubMed ID: 422930
[TBL] [Abstract][Full Text] [Related]
11. Control of methylxanthines in the competition horse: pharmacokinetic/pharmacodynamic studies on caffeine, theobromine and theophylline for the assessment of irrelevant concentrations.
Machnik M; Kaiser S; Koppe S; Kietzmann M; Schenk I; Düe M; Thevis M; Schänzer W; Toutain PL
Drug Test Anal; 2017 Sep; 9(9):1372-1384. PubMed ID: 27662634
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cocoa- and coffee-derived methylxanthines as toxicants for the control of pest coyotes.
Johnston JJ
J Agric Food Chem; 2005 May; 53(10):4069-75. PubMed ID: 15884841
[TBL] [Abstract][Full Text] [Related]
13. Caffeine, theophylline, theobromine, and developmental growth of the mouse mammary gland.
VanderPloeg LC; Wolfrom DM; Rao AR; Braselton WE; Welsch CW
J Environ Pathol Toxicol Oncol; 1992; 11(3):177-89. PubMed ID: 1625188
[TBL] [Abstract][Full Text] [Related]
14. The toxicology of cocoa and methylxanthines: a review of the literature.
Tarka SM
Crit Rev Toxicol; 1982; 9(4):275-312. PubMed ID: 6765610
[TBL] [Abstract][Full Text] [Related]
15. Coadministration of methylxanthines and inhibitor compounds potentiates teratogenicity in Xenopus embryos.
Dawson DA; Bantle JA
Teratology; 1987 Apr; 35(2):221-7. PubMed ID: 3603405
[TBL] [Abstract][Full Text] [Related]
16. Engineering a microbial platform for de novo biosynthesis of diverse methylxanthines.
McKeague M; Wang YH; Cravens A; Win MN; Smolke CD
Metab Eng; 2016 Nov; 38():191-203. PubMed ID: 27519552
[TBL] [Abstract][Full Text] [Related]
17. Glutathione-Mediated Neuroprotective Effect of Purine Derivatives.
Matsumura N; Aoyama K
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685879
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.
Chen JF; Xu K; Petzer JP; Staal R; Xu YH; Beilstein M; Sonsalla PK; Castagnoli K; Castagnoli N; Schwarzschild MA
J Neurosci; 2001 May; 21(10):RC143. PubMed ID: 11319241
[TBL] [Abstract][Full Text] [Related]
19. Spectral analysis of naturally occurring methylxanthines (theophylline, theobromine and caffeine) binding with DNA.
Johnson IM; Prakash H; Prathiba J; Raghunathan R; Malathi R
PLoS One; 2012; 7(12):e50019. PubMed ID: 23236361
[TBL] [Abstract][Full Text] [Related]
20. Testicular atrophy and impaired spermatogenesis in rats fed high levels of the methylxanthines caffeine, theobromine, or theophylline.
Weinberger MA; Friedman L; Farber TM; Moreland FM; Peters EL; Gilmore CE; Khan MA
J Environ Pathol Toxicol; 1978; 1(5):669-88. PubMed ID: 722208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]